Lactoferrin immunoexpression in endometrial carcinomas: Relationships with sex steroid hormone receptors (ER and PR), proliferation indices (Ki-67 and AgNOR) and survival

Oncology Reports

Volumn 16, Issue 2, 2006, Pages 257-263

  Giuffrè, Giuseppe ^a   Arena, Francesco ^a   Scarfì, Rosa ^a   Simone, Angela ^a   Todaro, Paolo ^a   Tuccari, Giovanni ^a  

^a UNIVERSITY OF MESSINA   (Italy)

Author keywords

AgNORs; Endometrial carcinoma; Ki 67; Lactoferrin; Steroid hormone receptors

Indexed keywords

CELL NUCLEUS ANTIGEN; ESTROGEN RECEPTOR; KI 67 ANTIGEN; LACTOFERRIN; NUCLEAR PROTEIN; NUCLEOLAR ORGANIZER REGION ASSOCIATED PROTEINS; PROGESTERONE RECEPTOR; SEX HORMONE; TUMOR MARKER;

ADULT; AGED; ARTICLE; CARCINOMA; CHEMISTRY; CYTOPLASM; ENDOMETRIUM TUMOR; FEMALE; HUMAN; METABOLISM; MIDDLE AGED; MITOSIS INDEX; MORTALITY; PATHOLOGY; PROGNOSIS; RISK;

ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, NUCLEAR; CARCINOMA; CYTOPLASM; ENDOMETRIAL NEOPLASMS; FEMALE; GONADAL STEROID HORMONES; HUMANS; KI-67 ANTIGEN; LACTOFERRIN; MIDDLE AGED; MITOTIC INDEX; NUCLEAR PROTEINS; PROGNOSIS; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; RISK; TUMOR MARKERS, BIOLOGICAL;

EID: 33748569470     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.16.2.257     Document Type: Article

References (48)

1. Johansson BG: Isolation of an iron containing red protein from human milk. Acta Chem Scand 14: 510-512, 1960.
2. Metz-Boutigue MH, Jolles J, Mazurier J, et al: Human lactotransferrin: amino acid sequence and structural comparison with other transferrins. Eur J Biochem 145: 659-676, 1984. (Pubitemid 15178137)
3. Anderson BF, Baker HM, Dodson EJ, et al: Structure of human lactoferrin at 3.2 - a resolution. Proc Natl Acad Sci USA 84: 1769-1773, 1987. (Pubitemid 17054094)
4. Masson PL, Heremans JF and Dire CH: An iron-binding protein common to many external secretions. Clin Chim Acta 14: 735-739, 1966.
5. De Vet BJCM and van Gool J: Lactoferrin and iron absorption in the small intestine. Acta Med Scand 196: 393-402, 1974.
6. Mason DY and Taylor CR: Distribution of transferrin, ferritin and lactoferrin human tissues. J Clin Pathol 31: 316-327, 1978. (Pubitemid 8315980)
7. Brock JH: Lactoferrin in human milk: its role in iron absorption and protection against enteric infection in the newborn infant. Arch Dis Child 55: 417-421, 1980.
8. Reitamo S, Kontinnen YT and Segerber-Kontinnen M: Distribution of lactoferrin in human salivary glands. Histochemistry 66: 285-291, 1980. (Pubitemid 10057401)
9. Korsrud FR and Brandtzaeg P: Characterization of epithelial elements in human major salivary glands by functional markers: localization of amylase, lactoferrin, lysozyme, secretory component and secretory immunoglobulins by paired immunofluorescence staining. J Histochem Cytochem 30: 657-666, 1982. (Pubitemid 13224408)
10. Cohen MS, Britigan BE, French M, et al: Preliminary observations on lactoferrin secretion in human vaginal mucus: variation during the menstrual cycle, evidence of hormonal regulation, and implications for infection with Neisseria gonorrhoeae. Am J Obstet Gynecol 157: 1122-1125, 1987. (Pubitemid 17163781)
11. Tedeschi A, Tuccari G, Magazzu G, et al : Immunohistochemical localization of lactoferrin in duodenojejunal mucosa from celiac children. J Pediatr Gastroenterol Nutr 6: 328-334, 1987. (Pubitemid 17073443)
12. Walmer DK, Padin CJ, Wrona MA, et al: Malignant transformation of the human endometrium is associated with overexpression of lactoferrin messenger RNA and protein. Cancer Res 55: 1168-1175, 1995.
13. Kelver ME, Kaul A, Nowicki B, et al: Estrogen regulation of lactoferrin expression in human endometrium. Am J Reprod Immunol 36: 243-247, 1996. (Pubitemid 26383974)
14. Yamashita S: Immunohistochemical study of estrogen-induced lactoferrin-like protein in the mouse uterus: localization in the nucleolus and secretory pathway. Acta Histochem Cytochem 28: 217-225, 1995.
15. Yanaihara A, Toma Y, Saito H, et al: Cell proliferation effect of lactoferrin in human endometrial stroma cells. Mol Hum Reprod 6: 469-473, 2000. (Pubitemid 30246713)
16. Teng CT, Gladwell W, Beard C, et al : Lactoferrin gene expression is estrogen responsive in human and rhesus monkey endometrium. Mol Hum Reprod 8: 58-67, 2002. (Pubitemid 34097663)
17. Tavassoli FA and Devilee P (eds). Pathology and genetics of tumours of the breast and female genital organs. World Health Organization Classification of Tumours. IARC Press, Lyon, 2000.
18. Zaino RJ, Kurman RJ, Diana KL, et al: The utility of the revised international federation of gynecology and obstetrics histologic grading of endometrial adenocarcinoma using a defined nuclear grading system. Cancer 75: 81-86, 1995.
19. Tuccari G, Villari D, Giuffrè G, et al: Immunohistochemical evidence of lactoferrin in hepatic biopsies of patients with viral or cryptogenetic chronic liver disease. Histol Histopathol 17: 1077-1083, 2002.
20. Öfner D, Aubele M, Biesterfeld S, et al: Guidelines of AgNOR quantification - first update. In: Cell Proliferation Assessment in Oncology. Hofstadter F, Knuchel R and Rüschoff J (eds). Virchows Arch 427: 341, 1995.
21. Giuffrè G, Caruso RA, Barresi G, et al: Prognostic significance of standardized AgNOR analysis in early and advanced gastric carcinomas. Virchows Arch 433: 261-266, 1998. (Pubitemid 28448682)
22. Giuffrè G, Fulcheri E, Gualco M, et al: Standardized AgNOR analysis as a prognostic parameter in endometrial carcinoma, endometrioid type. Analyt Quant Cytol Histol 23: 31-39, 2001.
23. Caselitz J, Jaup T and Seifert G: Lactoferrin and lysozyme in carcinomas of the parotid gland. Virchows Arch (A) 394: 61-73, 1981.
24. Barresi G and Tuccari G: Lactoferrin in benign hypertrophy and carcinomas of the prostatic gland. Virchows Arch (A) 403: 59-66, 1984. (Pubitemid 14103985)
25. Rossiello R, Carriero MV and Giordano GG: Distribution of ferritin, transferrin and lactoferrin in breast carcinoma tissue. J Clin Pathol 37: 51-55, 1984. (Pubitemid 14218063)
26. Charpin C, Lachard A, Pourreau-Schneider N, et al: Localization of lactoferrin and non-specific cross-reacting antigen in human breast carcinomas. Cancer 55: 2612-2617, 1985.
27. Tuccari G and Barresi G: Immunohistochemical demonstration of lactoferrin in follicular adenomas and thyroid carcinomas. Virchows Arch (A) 406: 67-74, 1985. (Pubitemid 15083762)
28. Barresi G and Tuccari G: Iron-binding proteins in thyroid tumours. An immunocytochemical study. Path Res Pract 182: 344-351, 1987. (Pubitemid 17111039)
29. Cabaret V, Vilain MO, Delobelle-Deroide A, et al: Détection immunohistochimique de la céruloplasmine et de la lactoferrine sur une sèrie de 59 tumeurs thyroidiennes. Ann Pathol 12: 347-352, 1992. (Pubitemid 23079917)
30. Asato de Camargo RY, Longatto Filho A, Ferreira Alves VA, et al: Lactoferrin in thyroid lesions. Immunoreactivity in fine needle aspiration biopsy samples. Acta Cytol 40: 408-413, 1996. (Pubitemid 26189667)
31. Loughlin KR, Gittes RF and Partridge D: The relationship of lactoferrin to the anemia of renal carcinoma. Cancer 59: 566-571, 1987. (Pubitemid 17002440)
32. Tuccari G, Barresi G, Arena F, et al: Immunocytochemical detection of lactoferrin in human gastric carcinomas and adenomas. Arch Pathol Lab Med 113: 912-916, 1989.
33. Tuccari G, Rizzo A, Crisafulli C, et al: Iron binding proteins in human colorectal adenomas and carcinomas: an immunocytochemical investigation. Histol Histopathol 7: 543-547, 1992.
34. Tuccari G, Rossiello R and Barresi G: Iron binding proteins in gallbladder carcinomas. An immunocytochemical investigation. Histol Histopathol 12: 671-676, 1997. (Pubitemid 27314698)
35. Tuccari G, Giuffrè G, Crisafulli C, et al: Immunohistochemical detection of lactoferrin in human astrocytomas and multiforme glioblastomas. Eur J Histochem 43: 317-322, 1999. (Pubitemid 30052189)
36. Tuccari G, Giuffrè G, Scarfì R, et al: Immunolocalization of lactoferrin in surgically resected pigmented skin lesions. Eur J Histochem 49: 33-38, 2005.
37. Garrè C, Bianchi-Scarra G, Sirito M, et al: Lactoferrin binding sites and nuclear localization in K562(S) cells. J Cell Physiol 153: 477-482, 1992.
38. Penco S, Scarfì S, Giovine M, et al: Identification of an import signal for, and the nuclear localization of, human lactoferrin. Biotechnol Appl Biochem 34: 151-159, 2001. (Pubitemid 33152512)
39. Sherman ME, Bur ME and Kurman RJ: p53 in endometrial cancer and its putative precursors: evidence for diverse pathways of tumorigenesis. Hum Pathol 26: 1268-1274, 1995.
40. Teng CT, Liu Y, Yang N, et al: Differential molecular mechanism of estrogen action that regulates lactoferrin gene in human and mouse. Mol Endocrinol 6: 1969-1981, 1992.
41. Hagiwara T, Shinoda I, Fukuwatari Y, et al: Effects of lactoferrin and its peptides on proliferation of rat intestinal epithelial cell line, IEC-18, in the presence of epidermal growth factor. Biosci Biotechnol Biochem 59: 1875-1881, 1995. (Pubitemid 3009687)
42. Damiens E, Mazurier J, El Yazidi I, et al : Effects of human lactoferrin on NK cell cytotoxicity against haematopoietic and epithelial tumour cells. Biochim Biophys Acta 1402: 277-287, 1998. (Pubitemid 28206922)
43. Damiens E, El Yazidi I, Mazurier J, et al: Lactoferrin inhibits G1 cyclin-dependent kinases during growth arrest of human breast carcinoma cells. J Cell Biochem 74: 486-498, 1999. (Pubitemid 29344898)
44. Tsuda H, Sekine K, Fujita K, et al: Cancer prevention by bovine lactoferrin and underlying mechanisms - a review of experimental and clinical studies. Biochem Cell Biol 80: 131-136, 2002. (Pubitemid 34194239)
45. Albright CD and Kaufman DG: Lactoferrin: a tamoxifen-responsive protein in normal and malignant human endometrial cells in culture. Exp Mol Pathol 70: 71-76, 2001. (Pubitemid 34412205)
46. Weinberg ED: Iron withholding: a defense against infection and neoplasia. Physiol Rev 64: 65-102, 1984.
47. Shoji A and Ozawa E: Necessity of transferrin for RNA synthesis in chick myotubes. J Cell Physiol 127: 349-356, 1986. (Pubitemid 16065385)
48. Weinberg ED: Human lactoferrin: a novel therapeutic with broad spectrum potential. J Pharm Pharmacol 53: 1303-1310, 2001.